Literature DB >> 7860414

Long-term results of treatment of cervical carcinoma in the United States in 1973, 1978, and 1983: Patterns of Care Study (PCS).

R Komaki1, T J Brickner, A L Hanlon, J B Owen, G E Hanks.   

Abstract

PURPOSE: To extend the observations of patients with carcinoma of the cervix treated in 1973 for over 15 years, in 1978 for over 10 years, and in 1983 for over 5 years for survival and local control to compare treatment times and outcome. METHODS AND MATERIALS: A nationwide survey of the patterns of practice in radiation therapy for patients with squamous carcinoma of the cervix collected pretreatment and treatment data using external surveyors who reviewed patients' records. Outcome information was updated for the three separate databases by mail survey. Overall survival, no evidence of disease (NED) survival, and local control curves by stage were plotted using the estimates derived by the Kaplan-Meier method.
RESULTS: Total number of patients surveyed was 1686: 937 patients in 1973, 565 patients in 1978, and 184 patients in 1983. These are the results from changes in treatment policy, particularly the increasing use of brachytherapy. Of Stage III patients, the percentage receiving brachytherapy was 60.5% in 1973, 76.5% in 1978, and 87.9% in 1983 (p < 0.001 by linear trend test). Also, there was an increased proportion in use of higher energy for external pelvic irradiation during the more recent time period, e.g., 28% in the 1973 study, 60% in the 1978 study, and 87% in the 1983 study compared to the usage of cobalt-60 equipment. Comparison of results including overall survival, local control, and NED survival for the three different time periods showed improvement in outcome for Stage III in 1983, but not Stages I and II. The 5-year survival for Stage III increased from 25% in the 1973 survey to 47% in the 1983 survey, a linear trend that is statistically significant (p = 0.02).
CONCLUSION: The long-term results of radiotherapy for patients with carcinoma of the cervix show improved outcome for Stage III patients, which probably results from improved treatment, including higher energy for pelvic irradiation and increase in use of brachytherapy contributing better local control and fewer complications.

Entities:  

Mesh:

Year:  1995        PMID: 7860414     DOI: 10.1016/0360-3016(94)00489-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Expression of Beclin 1 and LC3 in FIGO stage I-II cervical squamous cell carcinoma and relationship to survival.

Authors:  Weipei Zhu; Xiaohong Pan; Feng Li; Yongshen Zhang; Xueguan Lu
Journal:  Tumour Biol       Date:  2012-05-25

2.  Expression and prognostic significance of TAp73 and ΔNp73 in FIGO stage I-II cervical squamous cell carcinoma.

Authors:  Weipei Zhu; Xiaohong Pan; Zhujuan Yang; Pengfei Xing; Yongshen Zhang; Feng Li; Xueguan Lu
Journal:  Oncol Lett       Date:  2015-03-17       Impact factor: 2.967

3.  Redesign of process map to increase efficiency: Reducing procedure time in cervical cancer brachytherapy.

Authors:  Antonio L Damato; Larissa J Lee; Mandar S Bhagwat; Ivan Buzurovic; Robert A Cormack; Susan Finucane; Jorgen L Hansen; Desmond A O'Farrell; Alecia Offiong; Una Randall; Scott Friesen; Akila N Viswanathan
Journal:  Brachytherapy       Date:  2015-01-06       Impact factor: 2.362

4.  Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial.

Authors:  Frederick B Stehman; Shamshad Ali; Henry M Keys; Laila I Muderspach; Weldon E Chafe; Donald G Gallup; Joan L Walker; Deborah Gersell
Journal:  Am J Obstet Gynecol       Date:  2007-11       Impact factor: 8.661

5.  Clinico-epigenetic combination including quantitative methylation value of DKK3 augments survival prediction of the patient with cervical cancer.

Authors:  Woong-Sun Kang; Sung Bum Cho; Jun-Soo Park; Moo-Yul Lee; Soon-Chul Myung; Won Yong Kim; Sang-Hoon Lee; Dong-Ho Kim; Eun-Ju Lee
Journal:  J Cancer Res Clin Oncol       Date:  2012-09-09       Impact factor: 4.553

6.  Concurrent Chemoradiation for Cancer of the Cervix: Results of a Multi-Institutional Study From the Setting of a Developing Country (India).

Authors:  Ambakumar Nandakumar; Goura Kishor Rath; Amal Chandra Kataki; P Poonamalle Bapsy; Prakash C Gupta; Paleth Gangadharan; Ramesh C Mahajan; Manas Nath Bandyopadhyay; Elizabeth Vallikad; Rudrapatna N Visweswara; Francis Selvaraj Roselind; Krishnan Sathishkumar; Dampilla Daniel Vijaykumar; Ankush Jain; Kondalli Lakshminarayana Sudarshan
Journal:  J Glob Oncol       Date:  2015-09-23

7.  Adjuvant hysterectomy for treatment of residual disease in patients with cervical cancer treated with radiation therapy.

Authors:  T Ota; N Takeshima; T Tabata; K Hasumi; K Takizawa
Journal:  Br J Cancer       Date:  2008-10-21       Impact factor: 7.640

8.  Treatment of squamous cell carcinoma of the uterine cervix with radiation therapy alone: long-term survival, late complications, and incidence of second cancers.

Authors:  T Ota; N Takeshima; T Tabata; K Hasumi; K Takizawa
Journal:  Br J Cancer       Date:  2007-09-25       Impact factor: 7.640

Review 9.  Systematic review for non-surgical interventions for the management of late radiation proctitis.

Authors:  A S Denton; H J N Andreyev; A Forbes; E J Maher
Journal:  Br J Cancer       Date:  2002-07-15       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.